NCT02864264View on ClinicalTrials.gov

Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis

PHASE1TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

September 14, 2016

Primary Completion Date

September 27, 2017

Study Completion Date

September 27, 2017

Conditions
Healthy VolunteersUlcerative Colitis
Interventions
DRUG

BMS-986184

DRUG

Placebo matching BMS-986184

Trial Locations (3)

3004

Local Institution, Melbourne

0112

Local Institution, Tbilisi

MD-2025

Local Institution, Chisinau

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02864264 - Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis | Biotech Hunter | Biotech Hunter